Lupin receives approval from USFDA for Brexpiprazole Tablets
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subgroup analysis by HER2 expression from phase 1/2 trial of patients with HER3 expressing metastatic breast cancer highlighted in a second Presidential Session
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Subscribe To Our Newsletter & Stay Updated